Kadimastem (Israel) Buy Hold or Sell Recommendation
KDST Stock | ILA 485.00 35.00 6.73% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Kadimastem is 'Strong Sell'. Macroaxis provides Kadimastem buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding KDST positions. The advice algorithm takes into account all of Kadimastem's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Kadimastem's buy or sell advice are summarized below:
Real Value 437.72 | Hype Value 485 | Market Value 485 | Naive Value 495.42 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Kadimastem given historical horizon and risk tolerance towards Kadimastem. When Macroaxis issues a 'buy' or 'sell' recommendation for Kadimastem, the advice is generated through an automated system that utilizes algorithms and statistical models.
Kadimastem |
Execute Kadimastem Buy or Sell Advice
The Kadimastem recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Kadimastem. Macroaxis does not own or have any residual interests in Kadimastem or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Kadimastem's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Kadimastem Trading Alerts and Improvement Suggestions
Kadimastem generated a negative expected return over the last 90 days | |
Kadimastem has high historical volatility and very poor performance | |
The company has accumulated 12.96 M in total debt with debt to equity ratio (D/E) of 7.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Kadimastem has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Kadimastem until it has trouble settling it off, either with new capital or with free cash flow. So, Kadimastem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kadimastem sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kadimastem to invest in growth at high rates of return. When we think about Kadimastem's use of debt, we should always consider it together with cash and equity. | |
Net Loss for the year was (26.27 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Kadimastem has accumulated about 5.43 M in cash with (21.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. | |
Roughly 54.0% of Kadimastem outstanding shares are owned by corporate insiders |
Kadimastem Returns Distribution Density
The distribution of Kadimastem's historical returns is an attempt to chart the uncertainty of Kadimastem's future price movements. The chart of the probability distribution of Kadimastem daily returns describes the distribution of returns around its average expected value. We use Kadimastem price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Kadimastem returns is essential to provide solid investment advice for Kadimastem.
Mean Return | -0.29 | Value At Risk | -6.22 | Potential Upside | 5.56 | Standard Deviation | 4.36 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Kadimastem historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Kadimastem Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Kadimastem or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Kadimastem's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Kadimastem stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.27 | |
β | Beta against NYSE Composite | -0.4 | |
σ | Overall volatility | 4.76 | |
Ir | Information ratio | -0.09 |
Kadimastem Volatility Alert
Kadimastem exhibits very low volatility with skewness of 1.61 and kurtosis of 7.1. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Kadimastem's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Kadimastem's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Kadimastem Fundamentals Vs Peers
Comparing Kadimastem's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Kadimastem's direct or indirect competition across all of the common fundamentals between Kadimastem and the related equities. This way, we can detect undervalued stocks with similar characteristics as Kadimastem or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Kadimastem's fundamental indicators could also be used in its relative valuation, which is a method of valuing Kadimastem by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Kadimastem to competition |
Fundamentals | Kadimastem | Peer Average |
Return On Equity | -7.35 | -0.31 |
Return On Asset | -0.75 | -0.14 |
Current Valuation | 38.77 M | 16.62 B |
Shares Outstanding | 35.76 M | 571.82 M |
Shares Owned By Insiders | 53.72 % | 10.09 % |
Shares Owned By Institutions | 8.31 % | 39.21 % |
Price To Earning | (167.60) X | 28.72 X |
Price To Book | 5.90 X | 9.51 X |
EBITDA | (24.48 M) | 3.9 B |
Net Income | (26.27 M) | 570.98 M |
Cash And Equivalents | 5.43 M | 2.7 B |
Cash Per Share | 0.28 X | 5.01 X |
Total Debt | 12.96 M | 5.32 B |
Debt To Equity | 7.80 % | 48.70 % |
Current Ratio | 0.39 X | 2.16 X |
Book Value Per Share | 0.23 X | 1.93 K |
Cash Flow From Operations | (21.55 M) | 971.22 M |
Earnings Per Share | (1.11) X | 3.12 X |
Number Of Employees | 23 | 18.84 K |
Beta | 0.69 | -0.15 |
Market Capitalization | 30.32 M | 19.03 B |
Total Asset | 27.34 M | 29.47 B |
Retained Earnings | (88 M) | 9.33 B |
Working Capital | (6 M) | 1.48 B |
Current Asset | 5 M | 9.34 B |
Current Liabilities | 11 M | 7.9 B |
Z Score | -3.0 | 8.72 |
Net Asset | 27.34 M |
Kadimastem Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Kadimastem . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 740.84 | |||
Daily Balance Of Power | (0.47) | |||
Rate Of Daily Change | 0.93 | |||
Day Median Price | 522.45 | |||
Day Typical Price | 509.97 | |||
Market Facilitation Index | 0.0135 | |||
Price Action Indicator | (54.95) | |||
Period Momentum Indicator | (35.00) | |||
Relative Strength Index | 8.9 |
About Kadimastem Buy or Sell Advice
When is the right time to buy or sell Kadimastem? Buying financial instruments such as Kadimastem Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Kadimastem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Natural Foods Thematic Idea Now
Natural Foods
Companies producing natural foods including dairy products and different types of meets. The Natural Foods theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Natural Foods Theme or any other thematic opportunities.
View All Next | Launch |
Check out Kadimastem Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Kadimastem Stock analysis
When running Kadimastem's price analysis, check to measure Kadimastem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kadimastem is operating at the current time. Most of Kadimastem's value examination focuses on studying past and present price action to predict the probability of Kadimastem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kadimastem's price. Additionally, you may evaluate how the addition of Kadimastem to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |